Final approval was not given because of a patent issue; Biogen had a patent on its Tecfidera delayed-release capsules until an appeals court deemed it invalid in late 2021.
The FDA and Aurobindo Pharma did not reply to Becker’s requests for comment by publication time. This article will be updated if more information becomes available.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
